[
  {
    "info": {
      "NCT": "NCT03847519",
      "Protocol_No": "ADXS-503-101",
      "jit": "Tempus",
      "trial_name": "Advaxis ADXS-503-101"
    },
    "disease": {
      "summary": "Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer",
      "details": [
        {
          "code": "Lung Cancer",
          "selection": "include",
          "stage": "Metastatic"
        },
        {
          "code": "Lung Squamous Cell Carcinoma (LUSC)",
          "selection": "include",
          "stage": "Metastatic"
        },
        {
          "code": "Non-Small Cell Lung Cancer (NSCLC)",
          "selection": "include",
          "stage": "Metastatic"
        }
      ]
    },
    "query": {
      "nct": "NCT03847519",
      "title": "Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer",
      "current_status": "Recruiting",
      "status_verif_date": "July 2021",
      "last_update_date": "January 20, 2022",
      "trial_hold_status": "closed",
      "sponsor": "Advaxis, Inc.",
      "brief_summary": "A Phase 1/2, Open-Label Study of ADXS-503 Alone and in Combination with Pembrolizumab in Subjects with Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer",
      "conditions": "Lung Cancer, Non-Small Cell | Metastatic Squamous Cell Carcinoma | Metastatic Non-Squamous Cell Carcinoma",
      "type": "Interventional",
      "phase": "Phase 1 | Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "SoC SBRT + Durvalumab Therapy (Main Cohort)",
          "drug": "Durvalumab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "closed",
          "biomarker": [
            {
              "cohort": "SoC SBRT + Durvalumab Therapy (Main Cohort)",
              "Gene": "EGFR",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "exclude",
              "Function": "Not available",
              "summary": "EGFR Mutation  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "SoC SBRT + Placebo Therapy (Main Cohort)",
          "drug": "Other: Placebo",
          "arm_type": "Placebo Comparator",
          "line_of_therapy": "Not available",
          "arm_hold_status": "closed",
          "biomarker": [
            {
              "cohort": "SoC SBRT + Placebo Therapy (Main Cohort)",
              "Gene": "EGFR",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "exclude",
              "Function": "Not available",
              "summary": "EGFR Mutation  "
            }
          ]
        },
        {
          "ArmID": "3",
          "cohortlabel": "SoC SBRT + Osimertinib Therapy (Osimertinib cohort, single-arm, separate cohort)",
          "drug": "Osimertinib (single-arm, open-label)",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "closed",
          "biomarker": [
            {
              "cohort": "SoC SBRT + Osimertinib Therapy (Osimertinib cohort, single-arm, separate cohort)",
              "Gene": "EGFR",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "L858R",
              "Selection": "include",
              "Function": "Not available",
              "summary": "EGFR-TKI sensitivity L858R Mutation  "
            },
            {
              "cohort": "SoC SBRT + Osimertinib Therapy (Osimertinib cohort, single-arm, separate cohort)",
              "Gene": "EGFR",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Ex19del",
              "Selection": "include",
              "Function": "Not available",
              "summary": "EGFR-TKI sensitivity Ex19del Mutation  "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://therapies.securetempus.com/\" target=\"_blank\">Tempus<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-01-30",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT03847519\" target=\"_blank\">NCT03847519<\/a>"
    }
  }
]
